Giving a Hand: Synthetic Peptides Boost the Antifungal Activity of Itraconazole against .

is a multidrug-resistant pathogen responsible for infections in immunocompromised patients. Here, itraconazole (ITR), a commercial antifungal drug with low effectiveness against , was combined with different synthetic antimicrobial peptides (SAMPs), Mo-CBP3-PepII, RcAlb-PepII, RcAlb-PepIII, PepGAT, and PepKAA. The Mo-CBP3-PepII was designed based on the sequence of MoCBP3, purified from seeds. RcAlb-PepII and RcAlb-PepIII were designed using Rc-2S-Alb, purified from seed cakes. The putative sequence of a chitinase from was used to design PepGAT and PepKAA. All SAMPs have a positive liquid charge and a hydrophobic potential ranging from 41-65%. The mechanisms of action responsible for the combined effect were evaluated for the best combinations using fluorescence microscopy (FM). The synthetic peptides enhanced the activity of ITR by 10-fold against . Our results demonstrated that the combinations could induce pore formation in the membrane and the overaccumulation of ROS on cells. Our findings indicate that our peptides successfully potentialize the activity of ITR against . Therefore, synthetic peptides are potential molecules to assist antifungal agents in treating Cryptococcal infections.